The first combined meta‐analytic approach for elucidating the relationship of circulating resistin levels and RETN gene polymorphisms with colorectal and breast cancer

Egyptian Journal of Medical Human Genetics

Table 5 Analysis of publication bias in selected studies evaluating resistin level with colorectal and breast cancer

Cancer type	Sample type	Egger’s p-value	Begg-Mazumdar’s p-value
Colorectal cancer	Overall	0.044	0.280
	Serum	0.284	0.404
	Plasma	0.968	0.652
Breast cancer	Overall	0.0005	0.015
	Premenopausal	0.075	0.624
	Postmenopausal	0.005	0.532